ArticleFrontiers in immunology2026

DEB-TACE-HAIC combined with donafenib and camrelizumab in the treatment of unresectable hepatocellular carcinoma: a multicenter retrospective study.

Yuanjin Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.